The U.S. FDA approved Vanda
Pharmaceuticals drug to treat manic and mixed episodes
associated with a type of bipolar disorder, the company said on
Tuesday, marking the second approval for the.
The U.S. FDA approved Vanda
Pharmaceuticals drug to treat manic and mixed episodes
associated with a type of bipolar disorder, the company said on
Tuesday, marking the second approval for the.
(Reuters) -The U.S. FDA approved Vanda Pharmaceuticals drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said .
NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA). Such investors are